| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:531.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Laboratory of Cardiac Energetics (R.Y.K., A.E.S., S.R., A.H.A., N.G., J.D., T.F.C., R.S.B., A.E.A.), National Heart, Lung and Blood Institute, National Institutes of Health, and Suburban Hospital (R.Y.K., A.E.S., S.R., A.H.A., J.D., R.S.B., A.E.A.), Bethesda, Md.
Reprint requests to Andrew E. Arai, MD, Laboratory of Cardiac Energetics, National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Room BID416, MSC 106110 Center Dr, Bethesda, MD 20892-1061. E-mail araia{at}nih.gov
| Abstract |
|---|
|
|
|---|
Methods and Results The diagnostic performance of MRI was evaluated in a prospective study of 161 consecutive patients. Enrollment required 30 minutes of chest pain compatible with myocardial ischemia but an ECG not diagnostic of acute myocardial infarction. MRI was performed at rest within 12 hours of presentation and included perfusion, left ventricular function, and gadolinium-enhanced myocardial infarction detection. MRI was interpreted qualitatively but also analyzed quantitatively. The sensitivity and specificity, respectively, for detecting acute coronary syndrome were 84% and 85% by MRI, 80% and 61% by an abnormal ECG, 16% and 95% for strict ECG criteria for ischemia (ST depression or T-wave inversion), 40% and 97% for peak troponin-I, and 48% and 85% for a TIMI risk score
3. The MRI was more sensitive than strict ECG criteria for ischemia (P<0.001), peak troponin-I (P<0.001), and the TIMI risk score (P=0.004), and MRI was more specific than an abnormal ECG (P<0.001). Multivariate logistic regression analysis showed MRI was the strongest predictor of acute coronary syndrome and added diagnostic value over clinical parameters (P<0.001).
Conclusions Resting cardiac MRI exhibited diagnostic operating characteristics suitable for triage of patients with chest pain in the emergency department. Performed urgently to evaluate chest pain, MRI accurately detected a high fraction of patients with acute coronary syndrome, including patients with enzyme-negative unstable angina.
Key Words: emergency department magnetic resonance imaging myocardial infarction ischemia troponin
| Introduction |
|---|
|
|
|---|
Acute coronary syndrome (ACS) spans a broad classification,1 including ST-elevation myocardial infarction (STEMI), nonST-elevation myocardial infarction (NSTEMI), and unstable angina. On the basis of ECG and initial troponin levels, only a small percentage of patients with chest pain are clearly designated on presentation as having ACS. Although cardiac enzymes2 are extremely sensitive to myocardial infarction (MI), by definition, these assays do not detect unstable angina. Furthermore, it may take 4 to 12 hours after presentation before cardiac enzymes are definitive. It is well recognized that the ECG can be completely normal in acute MI and, therefore, also in unstable angina.
Missing the diagnosis of ACS doubles risk-adjusted mortality.3 Recent estimates indicate
2% of patients with MI are inappropriately discharged home from the ED.35 Consistent with the vulnerable plaque hypothesis, the consequences of not detecting unstable angina could result in progression to MI after discharge from the ED. Although troponin-negative patients seem to be at low risk,6 many patients with unstable angina require urgent medical therapy or intervention.
Advanced imaging that can detect unstable angina in addition to MI could improve triage of patients. We hypothesized that cardiac MRI at rest can effectively assess possible or probable ACS with a combined examination of regional contractile function, perfusion, and viability.
| Methods |
|---|
|
|
|---|
30 minutes of chest pain compatible with myocardial ischemia (chest pain score >4)7 within 12 hours before ED presentation, >21 years of age, and weight <270 pounds. Medical exclusions included STEMI, pregnancy, and severe congestive heart failure (unable to lie flat). MRI contraindications included pacemakers, defibrillators, cerebral aneurysm clips, metal in eye, and implanted devices such as insulin pumps, ear implants, or neural stimulators. We did not exclude patients with stents, artificial valves, anuloplasty rings, sternal wires, atrial fibrillation, or other cardiac history.
Definition of ACS and Ischemic Heart Disease
ACS was prospectively defined to satisfy guidelines established by the American College of Cardiology and the American Heart Association (ACC/AHA)1 with the following modifications. Possible or probable ACS required resting chest pain compatible with myocardial ischemia of
30 minutes duration within 12 hours of ED presentation (an entry criterion that excludes chronic stable angina). NSTEMI ACS required abnormal serial troponin-I (>1.96 µg/dL) with a temporal pattern consistent with acute MI and any clinical evidence of coronary artery disease. Confirmation of unstable angina required a 70% epicardial coronary stenosis or true positive abnormal stress test performed during the index hospitalization or subsequent 6- to 8-week follow-up period. For this study, ACS combines NSTEMI and unstable angina unless specifically noted.
Ischemic heart disease (IHD) was defined as any patient with ACS or prior MI. MRI was not used to define any end points. In the detection of ACS, an MRI was considered a true positive only if the findings were in the territory of a significant stenosis.
Imaging Protocol
Imaging was performed on a 1.5T scanner (CV/i, General Electric) using a cardiac phased-array receiver coil, research imaging sequences, and noninvasive monitoring (Medrad). Shim and center frequency were determined using stimulated echo acquisition mode.8 The diagnostic scan began with resting first-pass perfusion imaging using 0.1 mmol/kg intravenous gadopentetate dimeglumine (Berlex Laboratories), a selective saturation pulse,9 and a segmented echo- planar gradient echo readout10 to image 7 to 9 locations every 2 heartbeats (acquisition window, 123 to 163 ms/image; spatial resolution, 3.0 to 3.3 mm in-plane). Left ventricular function was imaged with fast-gradient recalled echo11 or fast imaging with steady-state precession12 at a temporal resolution of 40 to 50 ms and a spatial resolution of 1.8 to 2.0 mm in-plane. To detect MI, an inversion-recovery method13,14 was performed
20 minutes after a cumulative dose of 0.2 mmol/kg gadopentetate dimeglumine.
Qualitative MRI Analysis
Studies were read by the consensus of 3 cardiologists who were blinded to the study end point. An abnormal MRI required a regional wall motion abnormality15 or abnormal delayed gadolinium hyperenhancement. Abnormal delayed gadolinium hyperenhancement was defined as myocardium exhibiting higher signal intensity than the surrounding myocardium.16
Abnormal perfusion was defined as an area that did not enhance as bright as surrounding myocardium on several consecutive images coinciding with early peak myocardial enhancement. To accept a perfusion defect as a definite abnormality, there had to be a regional wall motion abnormality or delayed hyperenhancement in a matching location.
Quantitative MRI Analysis
Regional left ventricular wall thickness was measured at end-systole and end-diastole using computer-assisted calipers in the anterior septum, lateral wall, inferior septum, and any suspected regional wall motion abnormality. Indices of regional left ventricular function were calculated (absolute wall thickening in millimeters, percent change of wall thickness from end-diastole, and ratio of systolic to diastolic wall thickness).
The signal intensities of gadolinium-enhanced myocardium and normal myocardium were measured with computer-assisted planimetry. The contrast difference index was the difference in signal intensity between 2 regions divided by the standard deviation of the signal intensity in the normal region.16 The signal intensity ratio between the 2 regions was also calculated (contrast ratio).
Conventional Investigation
Serum troponin-I was typically collected on presentation and 4 and 8 hours later. The most abnormal ECG before or immediately after the MRI scan was selected for interpretation. An abnormal ECG was defined by the presence of T-wave inversion, ST-depression, bundle-branch block, left ventricular hypertrophy, non-specific ST-T changes, or pathological Q waves. Strict ECG criteria for ischemia required an ST depression
1 mm or a T-wave inversion
3 mm. Attending physicians made decisions to perform coronary angiography on clinical grounds independent of the MRI team. Conventional tests were read-blinded to final MRI readings. MRI findings were not used to determine the validity of conventional tests.
Statistical Methods
Logistic regression was performed to assess whether an abnormal MRI added diagnostic information over clinical parameters used to predict ACS. Rather than considering individual cardiac risk factors, the total number of cardiac risk factors (TlCRF) was defined as the number of the following that were present: advanced age (>45 for men, >55 for women), hypercholesterolemia, hypertension, diabetes mellitus, family history of coronary artery disease, tobacco use, and history of previous MI. Thus, the TlCRF ranged from 0 to 7. The other variables entered into the logistic models were an abnormal ECG (AbECG; 1 if abnormal, 0 if normal) and initial troponin-I (AbTn; 1 if abnormal, 0 if not). For the ACS end point, a model was formed with and without abnormal MRI (AbMRI; 1 if abnormal, 0 if normal). Let p be the probability of ACS. The following logistic regression models were considered.
The intercept and the coefficients represent the relative weighting of each variable and were estimated from the data using the logistic regression procedure of SAS (Version 6.12). Goodness of fit was assessed via the log likelihood. When the difference between "-2 log likelihood" for the model (which has a
2 distribution with one degree of freedom) is statistically significant, AbMRI adds significantly to the diagnostic information over the clinical parameters alone. The analysis used SAS version 6.12 (Statistical Analysis System, SAS Institute Inc).
Receiver-operating characteristic analysis was performed for each measurement to predict ACS. The sensitivity and specificity of an abnormal ECG, strict ECG criteria for ischemia, troponin, and the TIMI risk score were compared with MRI using a z-test that considered the correlation of diagnostic tests performed on the same subjects.
| Results |
|---|
|
|
|---|
|
The MRI scan lasted 38±12 minutes and patients were away from the ED for 58±10 minutes. A total of 137 patients (85%) had MRI before availability of the second troponin results. All MRIs were performed within 12 hours of presentation to the ED and before coronary angiography or noninvasive stress testing.
Diagnosis of ACS by Conventional Tests and Follow-Up
Follow-up was undertaken at 6 to 8 weeks to assure that no ACS was missed during the index hospitalization. Complete follow-up was achieved in 98% of patients. Troponin-I was available in 160 patients. The 3 patients with incomplete follow-up were all troponin-Inegative. A total of 22 of 25 patients had ACS diagnosed during the index hospitalization. Three patients were characterized as having ACS on the basis of the 6- to 8-week follow-up. One of these 3 patients returned with a STEMI, one returned 2 weeks later with unstable angina, and another had significant left anterior descending coronary artery disease on angiography after hospitalization.
Of the 161 patients studied, 16% had ACS (n=25), including 10 with NSTEMI (troponin-I, 2.96 to 44.1 ng/mL) and 15 with unstable angina. Several clinical parameters were significantly different between ACS-positive and -negative patients (Table 1), including the TIMI risk score.17 Of the 44 patients who underwent coronary angiography, 25 met the end point of ACS and 19 did not. Ten of the 15 patients with unstable angina had severe or
90% coronary stenosis (Figure 1), and the remaining had 70% to 90% stenosis. Fourteen of the 25 patients with ACS underwent coronary revascularization, including 7 with unstable angina. The ECG met strict criteria for ischemia in only 2 patients with NSTEMI and 2 patients with unstable angina. There were 4 false-positive troponins: 1 was attributed to cardiac sarcoidosis and 3 patients had atypical temporal patterns of cardiac enzymes and no significant abnormalities on coronary angiography.
|
Qualitative MRI Analysis
Qualitative MRI readings had a sensitivity of 84% (21 of 25 cases) in detecting ACS and a specificity of 85% (Figure 2). An abnormal ECG had a sensitivity of 80% (P=NS versus MRI) but a lower specificity of 61% (P<0.001 versus MRI). The sensitivity of strict ECG criteria for ischemia decreased to 16% (P<0.001 versus MRI), although the specificity (95%) was better than MRI (P=0.011). Troponin-I, either peak or initial, was not as sensitive to ACS as MRI (both P<0.001), but an abnormal troponin was more specific (P<0.001 versus MRI). A TIMI risk score
3 had 48% sensitivity and 85% specificity for ACS (P<0.001 and P=NS versus MRI, respectively). The attending physicians decision to admit a patient had a sensitivity of 88% and specificity of 55% for ACS.
|
Additional analysis was performed to understand better the diagnostic characteristics of MRI. For example, MRI detected all 10 NSTEMI, including the 3 patients with normal ECGs. However, because it was difficult to differentiate acute and chronic MI, it is important to analyze those patients with IHD, which encompasses both diagnoses. Thus, from the perspective of diagnosing ACS, all but 2 false-positive MRI scans can be explained by a prior MI.
Quantitative MRI Analysis
Quantitative MRI analysis is summarized in Table 2. Absolute wall thickening provided the best overall accuracy in detecting ACS (82%), NSTEMI (89%), and IHD (98%; Figure 3). A threshold of 3 mm of wall thickening detected 83% of ACS, all NSTEMI, and 91% of IHD.
|
|
Using a threshold of 5.0, the contrast difference index discriminated infarcted myocardium from normal myocardium and agreed in all cases with the qualitative reading. Compared with normal myocardium, the signal intensity of hyperenhanced myocardium averaged 14 standard deviations brighter (P<0.001). On the basis of the contrast ratio, infarcted myocardium was 4.1±0.8 times brighter than normal myocardium (P<0.001). Patients with unstable angina but no history of MI decreased the sensitivity of delayed gadolinium hyperenhancement images for ACS and IHD to 73% and 63%, respectively. For diagnosing ACS, the specificity of the contrast enhancement ratio was 91%.
Multivariate Logistic Regression Analysis
Abnormal MRI was the most significant test of those considered. In addition, abnormal MRI added significant independent diagnostic information to the other tests (Table 3, P<0.001 for model b compared with a).
|
The models had good overall fit, as demonstrated by their likelihood ratios (Table 3). For ACS, in the first model, total risk factors (TlCRF), ECG, and initial troponin-I were highly significant. When MRI was added to that model, total risk factors and ECG were no longer significant, whereas MRI was significant (P=0.0001). There was a high correlation between total risk factors (TlCRF), abnormal MRI, and ECG, which explained the lack of significance of these variables once MRI was added to the model. For prediction of ACS, the receiver-operating characteristic curves for the TIMI risk score and the current logistic regression models (with and without MRI) are displayed in Figure 4.
|
| Discussion |
|---|
|
|
|---|
Cardiac enzymes only detect the NSTEMI fraction of ACS. Perfusion may be normal between episodes of chest pain. However, regional wall motion may remain abnormal for hours after transient ischemia, a phenomenon known as myocardial stunning.18 With this background, it is not surprising that wall motion was the most powerful element of the MRI scan.
Radionuclide imaging for chest pain is the most developed modality for ED triage, with reports since 1979.19 The results for infarct detection have been excellent, particularly for the Tc-99mbased tracers.1925 However, there is room for improvement. In a cohort of 357 patients imaged acutely as part of an ED triage protocol, Heller et al24 reported normal images at rest in 12 of 35 patients (34%) who ultimately were diagnosed with ACS, including 2 with acute MI. Normal images were acquired in 7 of 32 patients with ACS (22%) in a cohort of >1000 patients with chest pain.22 In a multicenter trial of 102 ED patients with typical angina but nondiagnostic ECG, only 3 of 15 patients with unstable angina had abnormal sestamibi studies.21
Despite the relatively long period that acute imaging with radionuclides has been available, the technique has not been embraced on a large scale. Recently, an expert panel outlined the progress and difficulties with acute radionuclide imaging.26 These include isotope preparation, decay and licensing issues, a preponderance of small nuclear medicine laboratories with insufficient support to provide imaging 24 hours per day, and the difficulties associated with single-image interpretation without the customary second image for comparison. Other limitations include low spatial resolution and limited temporal resolution.
Echocardiography has had less impact in chest pain evaluation because of its limited sensitivity to acute MI, especially when the pain has resolved.27,28 Left ventricular systolic dysfunction detected by echocardiography has prognostic significance.29 Wall motion abnormalities may be subtle with subendocardial ischemia and difficult to visualize, with limited echocardiographic windows. In our experience, perfusion and delayed gadolinium hyperenhancement helped detect several cases with subtle wall motion abnormalities. However, reasonable judgment must be exercised to prevent overdiagnosis based on borderline abnormalities or the test specificity will degrade. Electron beam computer tomography had excellent negative predictive value but low specificity in patients with chest pain.30,31
MRI surmounts some of these barriers. Many hospitals have MRI capability for other emergencies such as stroke. Isotopes are not needed. Gadolinium is commercially available and well tolerated. Resolution, both spatially and temporally, is excellent. The multimodality characteristics of MRI provide 3 diagnostic opportunities. Wall motion can detect ischemia, postischemic stunning, and infarction. The gadolinium-enhanced methods help detect and characterize defects.
This study and others have validated the diagnostic utility of cardiac MRI for regional wall motion abnormality,32,33 perfusion,34,35 and viability.13,16,3638 The MRI can be quantified with high diagnostic accuracy (Table 2), but the images are also suitable for rapid qualitative interpretations (Table 3). Logistically, the MRI protocol was feasible in the ED and did not interfere with patient management.
Certain considerations will need to be addressed before MRI will have widespread application in the ED. Many hospitals possess instrumentation that could perform these studies but may require expensive software or hardware upgrades to achieve similar performance. Approximately 10% of patients were excluded, most commonly for claustrophobia. Newer magnet designs may reduce claustrophobia. Cost-effectiveness will need to be analyzed at a suitable point in the future.
Limitations
The foremost limitation for this study is the inability to differentiate acute from chronic infarction, a problem common to all noninvasive methods studied to date. Because the MRI detects both acute and chronic MI, the accuracy of MRI is higher for IHD than ACS (Figure 3). ACS represents a diverse pathophysiology: acute NSTEMI, unstable angina, spontaneously reperfused acute MI, 2-week-old MI with post-MI angina, extension of prior MI, and acute MI in one distribution but chronic MI in another distribution. We have not found criteria to differentiate acute from chronic MI in all cases. Nevertheless, either type of MI identifies a higher risk patient. Future advances may improve differentiation of acute and chronic MI. Despite these limitations, current MRI techniques had high sensitivity and specificity for ACS.
The definition of NSTEMI and unstable angina deviate somewhat from the ACC/AHA guidelines.1 Because the research protocol did not control decisions to perform coronary angiography, there is some potential for biasing the detection of disease. It is not clear if this would favor or go against the MRI. The skewed distribution favoring 90% to 99% stenosis rather than less severe stenosis suggests the patients identified as ACS were not incidental findings. Although our definition may have missed a few patients with ACS caused by less severe stenoses,39 it should be noted that 8% of our ACS group would have been categorized as having no significant coronary artery disease in the study by Roe et al39 (diagonal disease, Table 2). Limitations aside, chest pain evaluation with MRI seems promising because it can detect unstable angina and MI.
| Acknowledgments |
|---|
Received August 2, 2002; revision received October 14, 2002; accepted October 15, 2002.
| References |
|---|
|
|
|---|
2. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997; 337: 16481653.
3. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000; 342: 11631170.
4. Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol. 1987; 60: 219224.[CrossRef][Medline] [Order article via Infotrieve]
5. McCarthy BD, Beshansky JR, DAgostino RB, et al. Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. Ann Emerg Med. 1993; 22: 579582.[CrossRef][Medline] [Order article via Infotrieve]
6. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996; 335: 13421349.
7. Weinblatt E, Frank CW, Shapiro S, et al. Prognostic factors in angina pectoris: a prospective study. J Chronic Dis. 1968; 21: 231245.[CrossRef][Medline] [Order article via Infotrieve]
8. Haase A, Frahm J, Matthaei D, et al. MR imaging using stimulated echoes (STEAM). Radiology. 1986; 160: 787790.
9. Slavin GS, Wolff SD, Gupta SN, et al. First-pass myocardial perfusion MR imaging with interleaved notched saturation: feasibility study. Radiology. 2001; 219: 258263.
10. Ding S, Wolff SD, Epstein FH. Improved coverage in dynamic contrast-enhanced cardiac MRI using interleaved gradient-echo EPI. Magn Reson Med. 1998; 39: 514519.[Medline] [Order article via Infotrieve]
11. Feinstein JA, Epstein FH, Arai AE, et al. Using cardiac phase to order reconstruction (CAPTOR): a method to improve diastolic images. J Magn Reson Imaging. 1997; 7: 794798.[Medline] [Order article via Infotrieve]
12. Barkhausen J, Ruehm SG, Goyen M, et al. MR evaluation of ventricular function: true fast imaging with steady- state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology. 2001; 219: 264269.
13. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 19922002.
14. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218: 215223.
15. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two- dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2: 358367.[Medline] [Order article via Infotrieve]
16. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 14451453.
17. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000; 284: 835842.
18. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982; 66: 11461149.
19. Wackers FJ, Sokole EB, Samson G, et al. Value and limitations of thallium-201 scintigraphy in the acute phase of myocardial infarction. N Engl J Med. 1976; 295: 15.[Abstract]
20. Varetto T, Cantalupi D, Altieri A, et al. Emergency room technetium-99 m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol. 1993; 22: 18041808.[Abstract]
21. Hilton TC, Thompson RC, Williams HJ, et al. Technetium-99 m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol. 1994; 23: 10161022.[Abstract]
22. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997; 29: 116125.[CrossRef][Medline] [Order article via Infotrieve]
23. Kontos MC, Jesse RL, Schmidt KL, et al. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol. 1997; 30: 976982.[Abstract]
24. Heller GV, Stowers SA, Hendel RC, et al. Clinical value of acute rest technetium-99 m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms [see comments]. J Am Coll Cardiol. 1998; 31: 10111017.
25. Duca MD, Giri S, Wu AH, et al. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes. J Nucl Cardiol. 1999; 6: 570576.[CrossRef][Medline] [Order article via Infotrieve]
26. Heller GV, Udelson JE, Ziffer J, et al. Assessing suspected acute cardiac ischemia in the emergency department: logistics, testing modalities, implications for perfusion imaging. J Nucl Cardiol. 2001; 8: 274285.
27. Peels CH, Visser CA, Kupper AJ, et al. Usefulness of two-dimensional echocardiography for immediate detection of myocardial ischemia in the emergency room. Am J Cardiol. 1990; 65: 687691.[CrossRef][Medline] [Order article via Infotrieve]
28. Sabia P, Afrookteh A, Touchstone DA, et al. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction: a prospective study using two-dimensional echocardiography. Circulation. 1991; 84: I85I92.[Medline] [Order article via Infotrieve]
29. Sabia P, Abbott RD, Afrookteh A, et al. Importance of two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms. Circulation. 1991; 84: 16151624.
30. Laudon DA, Vukov LF, Breen JF, et al. Use of electron-beam computed tomography in the evaluation of chest pain patients in the emergency department. Ann Emerg Med. 1999; 33: 1521.[CrossRef][Medline] [Order article via Infotrieve]
31. McLaughlin VV, Balogh T, Rich S. Utility of electron beam computed tomography to stratify patients presenting to the emergency room with chest pain. Am J Cardiol. 1999; 84: 327328.[CrossRef][Medline] [Order article via Infotrieve]
32. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999; 99: 763770.
33. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999; 100: 16971702.
34. Al Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000; 101: 13791383.
35. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103: 22302235.
36. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995; 92: 19021910.
37. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q- wave and non-Q-wave myocardial infarction. Lancet. 2001; 357: 2128.[CrossRef][Medline] [Order article via Infotrieve]
38. Ricciardi MJ, Wu E, Davidson CJ, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001; 103: 27802783.
39. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndrome who do not have significant coronary artery disease. Circulation. 2000; 102: 11011106.
This article has been cited by other articles:
![]() |
R. C. Cury, K. Shash, G. Rosito, M. D. Shapiro, C. H. Nomura, S. Abbara, F. Bamberg, M. Ferencik, E. J. Schmidt, U. Hoffmann, et al. Response to Letter Regarding Article, "Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department" Circulation, May 5, 2009; 119(17): e524 - e524. [Full Text] [PDF] |
||||
![]() |
E. Nagel, J. A.C. Lima, R. T. George, and C. M. Kramer Newer methods for noninvasive assessment of myocardial perfusion cardiac magnetic resonance or cardiac computed tomography? J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 656 - 660. [Full Text] [PDF] |
||||
![]() |
T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF] |
||||
![]() |
R. C. Cury, K. Shash, J. T. Nagurney, G. Rosito, M. D. Shapiro, C. H. Nomura, S. Abbara, F. Bamberg, M. Ferencik, E. J. Schmidt, et al. Cardiac Magnetic Resonance With T2-Weighted Imaging Improves Detection of Patients With Acute Coronary Syndrome in the Emergency Department Circulation, August 19, 2008; 118(8): 837 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Selvanayagam Women with chest pain expanding the diagnostic armamentarium. J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 446 - 449. [Full Text] [PDF] |
||||
![]() |
U Ekelund and J L Forberg New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department Postgrad. Med. J., February 1, 2008; 84(988): 83 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Ekelund and J L Forberg New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department Emerg. Med. J., December 1, 2007; 24(12): 811 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. White and D. Kuo Chest Pain in the Emergency Department: Role of Multidetector CT Radiology, December 1, 2007; 245(3): 672 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
J P Greenwood, J F Younger, J P Ridgway, M U Sivananthan, S G Ball, and S Plein Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction Heart, November 1, 2007; 93(11): 1363 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Martin, B. A. Groenning, H. M. Murray, T. Steedman, J. E. Foster, A. T. Elliot, H. J. Dargie, R. H. Selvester, O. Pahlm, and G. S. Wagner ST-Segment Deviation Analysis of the Admission 12-Lead Electrocardiogram as an Aid to Early Diagnosis of Acute Myocardial Infarction With a Cardiac Magnetic Resonance Imaging Gold Standard J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1021 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660. [Full Text] [PDF] |
||||
![]() |
C. Jahnke, E. Nagel, R. Gebker, T. Kokocinski, S. Kelle, R. Manka, E. Fleck, and I. Paetsch Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging Circulation, April 3, 2007; 115(13): 1769 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, H. Abdel-Aty, I. Kriedemann, J. Schulz-Menger, C. M. Gross, R. Dietz, and M. G. Friedrich Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging of Right Ventricular Infarction J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1969 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Cury, C. A. M. Cattani, L. A. G. Gabure, D. J. Racy, J. M. de Gois, U. Siebert, S. S. Lima, and T. J. Brady Diagnostic Performance of Stress Perfusion and Delayed-Enhancement MR Imaging in Patients with Coronary Artery Disease. Radiology, July 1, 2006; 240(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. White Invited Commentary RadioGraphics, July 1, 2006; 26(4): 979 - 980. [Full Text] [PDF] |
||||
![]() |
R. Y. Kwong, A. K. Chan, K. A. Brown, C. W. Chan, H. G. Reynolds, S. Tsang, and R. B. Davis Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease Circulation, June 13, 2006; 113(23): 2733 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kramer When Two Tests Are Better Than One: Adding Late Gadolinium Enhancement to First-Pass Perfusion Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1639 - 1640. [Full Text] [PDF] |
||||
![]() |
W. P. Ingkanisorn, R. Y. Kwong, N. S. Bohme, N. L. Geller, K. L. Rhoads, C. K. Dyke, D. I. Paterson, M. A. Syed, A. H. Aletras, and A. E. Arai Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1427 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Piazza and S. Z. Goldhaber The Acutely Decompensated Right Ventricle: Pathways for Diagnosis and Management Chest, September 1, 2005; 128(3): 1836 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. White, D. Kuo, M. Kelemen, V. Jain, A. Musk, E. Zaidi, K. Read, C. Sliker, and R. Prasad Chest Pain Evaluation in the Emergency Department: Can MDCT Provide a Comprehensive Evaluation? Am. J. Roentgenol., August 1, 2005; 185(2): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Plein, J. P. Greenwood, J. P. Ridgway, G. Cranny, S. G. Ball, and M. U. Sivananthan Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2173 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kramer The comprehensive approach to ischemic heart disease by cardiovascular magnetic resonance imaging: Are we there yet? J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2182 - 2184. [Full Text] [PDF] |
||||
![]() |
A. Gupta, V. S. Lee, Y.-C. Chung, J. S. Babb, and O. P. Simonetti Myocardial Infarction: Optimization of Inversion Times at Delayed Contrast-enhanced MR Imaging Radiology, December 1, 2004; 233(3): 921 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF] |
||||
![]() |
R. R. Edelman Contrast-enhanced MR Imaging of the Heart: Overview of the Literature Radiology, September 1, 2004; 232(3): 653 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Arai and G. A. Hirsch Q-wave and non-q-wave myocardial infarctions through the eyes of cardiac magnetic resonance imaging J. Am. Coll. Cardiol., August 4, 2004; 44(3): 561 - 563. [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe and H. Katus Acute Coronary Syndrome Biomarkers: The Need for More Adequate Reporting Circulation, July 13, 2004; 110(2): 104 - 106. [Full Text] [PDF] |
||||
![]() |
D. C. Lee, O. P. Simonetti, K. R. Harris, T. A. Holly, R. M. Judd, E. Wu, and F. J. Klocke Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity Circulation, July 6, 2004; 110(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. O'Neill and S. R. Dixon The year in interventional cardiology J. Am. Coll. Cardiol., March 3, 2004; 43(5): 875 - 890. [Full Text] [PDF] |
||||
![]() |
V. S. Lee, D. Resnick, S. S. Tiu, J. J. Sanger, C. A. Nazzaro, G. M. Israel, and O. P. Simonetti MR Imaging Evaluation of Myocardial Viability in the Setting of Equivocal SPECT Results with 99mTc Sestamibi Radiology, January 1, 2004; 230(1): 191 - 197. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |